Biosimilars Research

Learn more about AMCP Research Institute. Our vision is to become the trusted source of evidence, innovation, and insights shaping the future of managed care pharmacy — through strategic partnerships, advanced data capabilities, and collaborative research.

The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research.

Host Fred Goldstein discusses current biologic options and the impact to the Immunology Market landscape with Michael Rothrock MHA, MBA, and Chronis H. Manolis, RPh.

2023 will be a pivotal year for biosimilar success or failure. Health care expert Fred Goldstein sits down with Stanton Mehr of Biosimilars Review & Report, to discuss what lies in store for biosimilars and AMCP’s biosimilar initiatives this year.